Dentine biomodification by sulphonamides pre-treatment: bond strength, proteolytic inhibition, and antimicrobial activity

J Enzyme Inhib Med Chem. 2023 Dec;38(1):319-329. doi: 10.1080/14756366.2022.2150184.

Abstract

We evaluated the effects of dentine biomodification after pre-treatment with two sulphonamide carbonic anhydrase inhibitors (CAIs) of the N-[4-sulphamoylphenethylcarbamoyl]benzenesulphonamide type, investigating matrix metalloproteases activity, resin-dentine micro tensile bond strength, dentine surface wettability, and antimicrobial activities. Ninety-five sound-extracted human molars were selected for the study. Inhibitory effects were evaluated by gelatinase and collagenase activity tests and collagen degradation FT-IR spectroscopic analysis. Pre-treatment with the two CAIs kept the micro tensile values after 12 months of storage (32.23 ± 5.95) and cariogenic challenge (34.13 ± 2.71) similar to the initial, pre-treatment values (33.56 ± 4.34). A decreased Streptococcus mutans biofilm formation on dentine surfaces and antibacterial activity against planktonic bacteria were observed after CAI treatment. Dentine pre-treatment with sulphonamide CAIs maintained adhesion strength stability, allowed better dentine wettability, maintained matrix collagen, and showed anti-S. mutans activity.

Keywords: Carbonic anhydrase inhibitor; Streptococcus mutans biofilm; antimicrobial activity; dentine; metalloproteinases.

MeSH terms

  • Anti-Infective Agents* / pharmacology
  • Collagen
  • Dentin* / chemistry
  • Humans
  • Spectroscopy, Fourier Transform Infrared
  • Sulfonamides / pharmacology

Substances

  • Sulfonamides
  • Collagen
  • Anti-Infective Agents

Grants and funding

The work was funded in part by the European Union’s Horizon 2020 research and innovation program under grant agreement No 951883, SPRINGBOARD (to CTS).